March 9, 2010 — Tecan has become ForteBio’s preferred automation partner for real-time, label-free assays to support bioprocess and drug discovery workflows. The two companies have worked together to integrate the new ForteBio Octet® 384 platform,… Read More

Sunnyvale, CA, February 03, 2010 - Today, Molecular Devices, Inc.-now part of Danaher Corporation-re-launched the Molecular Devices brand into the life sciences marketplace. The renewed corporate brand is focused primarily on meeting customer needs and… Read More

Washington, D.C., February 1, 2010 -- Danaher Corporation (NYSE: DHR) announced today that it has completed the previously announced acquisition of AB SCIEX and Molecular Devices. AB SCIEX is a leading designer and manufacturer of mass spectrometers,… Read More

MENLO PARK, CA, January 11, 2010 — ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the launch of its new Dip and Read Residual Protein A… Read More

SUNNYVALE, CA, December 16, 2009 - MDS Analytical Technologies, a leader in innovative solutions for drug discovery and life-sciences research, today announced the launch of the Molecular Devices® SpectraTest® LM1 Luminescence Validation Package.   The… Read More

SUNNYVALE, CA, December 16, 2009 - MDS Analytical Technologies, a leader in innovative solutions for drug discovery and life-sciences research, today announced the launch of the Molecular Devices® SpectraMax® M3 and M4 Multi-Mode Microplate Readers.… Read More

Extends Menu of Applications Available on Company's Octet® Platform

MENLO PARK, CA, September 16, 2009 — ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, announced today that it has launched the new Dip and Read Immunogenicity… Read More

MENLO PARK, CA, June 22, 2009 — ForteBio, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, announced today that it has launched two next-generation instruments: the Octet… Read More

MENLO PARK, CA, May 27, 2009 — ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced that it has launched two new assay modules — for high-sensitivity… Read More

SUNNYVALE, CA, April 27, 2009 /PRNewswire-FirstCall via COMTEX/ - MDS Analytical Technologies, a leader in innovative solutions for drug discovery and life sciences research, today announced at the Society for Biomolecular Sciences (SBS) Conference and… Read More